Peer Review History
| Original SubmissionSeptember 9, 2020 |
|---|
|
PONE-D-20-28394 Unequal access to timely physiotherapy for children with Cerebral Palsy: a retrospective chart review PLOS ONE Dear Dr. Johansen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses all points raised during the review process. Please submit your revised manuscript by Mar 29 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Christos Papadelis, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Methods section, please provide additional information regarding the participant inclusion and exclusion criteria. Furthermore, we note that you have reported significance probabilities of 0 in places. Since p=0 is not strictly possible, please correct this to a more appropriate limit, eg 'p<0.0001' 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating the following in the Competing Interests section: "SOMP-I is owned by Barnens rörelsebyrå ekonomisk förening (economic association) Uppsala, Sweden. Kine Johansen is a partner of Barnens rörelsebyrå. All other authors have no conflicts of interest to disclose." Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors retrospectively reviewed patient data from two health care systems in a county in Sweden in the aim to assess whether children with cerebral palsy (CP) have equal access to timely physiotherapy. They concluded from the data that Children with CP have unequal access to physiotherapy. The authors emphasized the importance of timely access of physiotherapy to children with CP. The data and results might be helpful for the improvement of local health policy for children with CP. The authors provided detailed descriptive results of data. However, the description of data collection is not detailed. Several aspects of information as the following should be described: (1) as a retrospective review, do you have a data collection guidance or standard, which is like on what data to be reviewed , how to collect data, and data quality control, before the formal data review? if so, please provide a data collection flow chart. (2) as described in the manuscript, the first author reviewed most of the data from two different health care systems, is there the possibility of any potential bias on reviewing data from two different health care systems mostly by one researcher, has any potential bias been considered to be controlled before formal data review, has any preventive method been used to control the bias? (3) the authors did not mention any data missing in the manuscript. How has data missing been handled if you did have the cases of missing data? As to statistical analysis, the authors used Kruskal-Wallis H Test but without providing any justification for the selection of this method. As to results, the authors found that both referral source and number of risk factors have significant influences to the first visit to physiotherapy (see Table 2), and concluded that “children referred from the child health services have the most delayed access” (see abstract conclusion). A likely scenario is that number of risk factors dominates the decision of the first visit to physiotherapy but children with CP from the child health services have the fewer number of risk factors compared to other referral sources, and the fewer number of risk factors caused the delay of referral of children with CP to physiotherapy by the child health services. If the number of risk factors was controlled, is the conclusion “children referred from the child health services have the most delayed access” still correct? Reviewer #2: The purpose of the review is to provide the editors with an expert opinion regarding the validity and quality of the manuscript under consideration. The review should also supply authors with explicit feedback on how to improve their papers so that they will be acceptable for publication in PLOS ONE. As you write, consider the following points: • What are the main claims of the paper and how significant are they for the discipline? I appreciate the opportunity to review the manuscript named “Unequal access to timely physiotherapy for children with Cerebral Palsy: a retrospective chart review” -The authors claims to investigate whether children with cerebral palsy (CP) in Sweden have equal access to timely physiotherapy. Additionally, the children’s birth history and CP profile are described to understand typical features that might enable earlier identification for children with CP in the future. Equity in care is important and it is clearly of interest to know if it is provided for children with CP, as that would be a prerequisite in order to correctly target suitable measures. However, I would also suggest nuancing the results with regard to motor function and need of physiotherapy, further discussed in comments below. • Are the claims properly placed in the context of the previous literature? Have the authors treated the literature fairly? -Yes, however the literature may also provide further information for nuancing according to gross motor function, mentioned above. • Do the data and analyses fully support the claims? If not, what other evidence is required? -Data sufficiently supports the claims. Multilevel regressions may be considered. • PLOS ONE encourages authors to publish detailed protocols and algorithms as supporting information online. Do any particular methods used in the manuscript warrant such treatment? If a protocol is already provided, for example for a randomized controlled trial, are there any important deviations from it? If so, have the authors explained adequately why the deviations occurred? -No need. • If the paper is considered unsuitable for publication in its present form, does the study itself show sufficient potential that the authors should be encouraged to resubmit a revised version? -Yes, I suggest a revised version to be resubmitted • Are original data deposited in appropriate repositories and accession/version numbers provided for genes, proteins, mutants, diseases, etc.? -Not applicable • Are details of the methodology sufficient to allow the experiments to be reproduced? -Yes • Is the manuscript well organized and written clearly enough to be accessible to non-specialists? -The manuscript should be revised more thoroughly for structure and readability, suggestions follows below. Although confidential comments to the editors are respected, any remarks that might help to strengthen the paper should be directed to the authors themselves. Explicit feedback for improvement: I thank you for letting me read and comment on your work, which I find important and interesting. I start of with general comments and proceed with specific comments referring to line numbers. I would recommend you to ethically reconsider some of the presented data due to confidentiality of the participants, further commented below. I would think it is of interest to nuance the discussion regarding need for physiotherapy and motor function. This study, like earlier cited studies shows roughly that when disability is not expected or fairly invisible, diagnosis/referral is more likely to be delayed. Conceivably these children are not the ones most in need of physiotherapy, thus, the consequences of less early physiotherapy may not be quite generalizable for all children with CP. For ease of reading, consider using the same wording throughout the document, e.g. medical history/complicated birth history, and also to provide both numbers and percentages. Introduction: 51: Please provide a reference for this statement. 52-53: Children with complicated birth history are enrolled to neonatal follow-up, which may be confused with information in methods, lines 79-80 where neonatal follow-up is only for children born <32 weeks. Please clarify criteria for neonatal follow-up 54-56: I would appreciate a more specific description of the knowledge gap – why this needs to be explored again but specifically for physiotherapy. 57: “Improve outcomes” is very general, please specify/exemplify interventions and outcomes and possibly for which children (GMFCS) 63: Is it possible that early motor interventions are more important for children with GMFCS III-V, and thereby lessening the impact of the inequality in timely physiotherapy, as all but one(!) from the well child visits had GMFCS I-II? While such information should not lead to disregarding of inequality, it would all the same nuance the picture. Method: 72-74: Exclusion criteria seems to exclude all children not born in Uppsala regardless of when they moved to Uppsala? Please clarify the exclusion criteria and the reasons for it as excluded children correspond to almost 50% of your current sample 78-79: Do all term born children always participate in the well child program? 79-80: Please clarify which children receives neonatal follow-up and how neonatologist differs from neuropediatrician. According to line 52-53, neonatal follow-up would not only include <32 weeks. Do the preterm children also participate in the well child program? 82: The neuropediatricians seem to be part of the neonatal follow-up, which further complicates the relevance of this division of referral source, see lines 52 and 79. 102: Please consider if multilevel analysis would be useful, e.g. multivariable logistic regressions. 109, Ethics: I disagree with your statement that all data are presented on group level. Some groups consists of single children. In a fairly small community of children with CP and their parents, in a named region in Sweden, there would be a significant risk that individual children are identified by some of these data. This would be particularly unfortunate since no informed consent is collected. Results: 117-118: Please clarify the meaning of “missed early” and why this is reason for exclusion. Table 1: In the rows you explain that you report n (%), however the percentages are summed up by column. I would recommend you to reconsider this way of presenting in order to gain readability 120-121: Please explain the relevance of the difference between being referred by neonatologist or neuropetiatrician – are these children not part of the same neonatal follow-up? Also, is it possible that CHS does not refer to physiotherapist directly, but via e.g. neuropediatricians, thus contributing to the delay? Table 2: It would be helpful if you explain H and Df among the abbreviations in the table and also elaborate the table heading so that the table can be understood separately from the text. GMFCS is quite close to significant regarding first visit to physiotherapy – I propose you add to the discussion whether your results actually show that there is no difference with regard to GMFCS or if the results may be due to power-issues. Discussion: 169: It is a bit unclear if you refer to the Ref 12 or to own results (or both) 172: As mentioned above, I find it a difficult to follow this grouping of children due to referral source – which are the children who are not from CHS and not in the neonatal follow-up There is a lack of consistency and/or a need of a more concise description throughout the manuscript 175-176: Again, as mentioned earlier, I would suggest you elaborate around this matter. While it is important to provide equal care, as to receive early FT assessment, there may also be limited consequences for children with mild motor difficulties to be referred to physiotherapy at a higher age, because of their fairly good motor function(?). Other difficulties associated with CP may be prioritized when motor function is good, such as e.g. speech or cognition. 178: Please clarify if the early interventions refer to physiotherapy or other interventions. Please consider discussion about power in your study when discussing GMFCS as not significantly associated with early referral to physiotherapist. 205-206: It seems in this statement like all children are not included in the neonatal follow-up – is that right and if so, please state this more clearly. According to the introduction line 52 all children with complicated birth history are routinely included. 206: Please specify which interventions and which guidelines you refer to. 216: Please specify the kind of review you refer to. 220-232: To implement use of evidence based motor assessment tools within CHS seems to be a suitable suggestion in order to early detect more children with presumed CP. I suggest you emphasize this even more. (As there is a shortage of specialist CHS nurses in primary care, maybe such assessment could be introduced as a cooperation task for primary health care physiotherapists in order to widen their area of responsibility and thereby strengthening their professional role?) ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Yanlong Song Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-20-28394R1 Early access to physiotherapy for infants with Cerebral Palsy: a retrospective chart review PLOS ONE Dear Dr. Johansen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 19 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Christos Papadelis, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have revised the manuscript thoroughly, and overall revisions are clear and logical. A main point I still have is on the regression analysis. Firstly, the authors did not state the regression models they used are linear or nonlinear. Secondly, the names of regressions the authors used, univariate regression and multivariate regression, are confusing. In both regression analysis, there is only one outcome variable (age at the first visit to a physiotherapist), thus the regressions should be named as simple (linear, I assume) regression for that with only one predictor and multiple (linear, I assume) regression for that with more than one predictors. Thirdly, as to the multivariate regression, the authors did not include an interaction item on referral source * number of risk factors. As mentioned before, I think there may exist interaction effect between referral source and number of risk factors. I am interested in that if the interaction item on referral source * number of risk factors was added in the multivariate regression, how would the results be? Reviewer #2: Thank you for the opportunity to re-review this manuscript. Major revisions are made to the manuscript, which greatly have improved it's quality, readability and arguments. All my queries are addressed. I have no further comments. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Yanlong Song Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Early access to physiotherapy for infants with cerebral palsy: a retrospective chart review PONE-D-20-28394R2 Dear Dr. Johansen, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Christos Papadelis, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-28394R2 Early access to physiotherapy for infants with cerebral palsy: a retrospective chart review Dear Dr. Johansen: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Christos Papadelis Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .